BM 16.2224 (BM 24)
a dibenz(b,e)oxepine derivative; inhibits secreted phospholipase A2 (sPLA2)
Also Known As:
BM 24; BM 162224; BM-16.2224; BM-24; BM24
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Doi, Hiroshi:
1 article
(04/2020)
|
2. | Doi, Katsumi:
1 article
(04/2020)
|
3. | Hyodo, Tomoko:
1 article
(04/2020)
|
4. | Ishii, Kazunari:
1 article
(04/2020)
|
5. | Kashiwagi, Nobuo:
1 article
(04/2020)
|
6. | Kitano, Mutsukazu:
1 article
(04/2020)
|
7. | Kozuka, Takenori:
1 article
(04/2020)
|
8. | Nakanishi, Katsuyuki:
1 article
(04/2020)
|
9. | Suzuki, Ayako:
1 article
(04/2020)
|
10. | Tsurusaki, Masakatsu:
1 article
(04/2020)
|
Related Diseases
Related Drugs and Biologics